CHK2, Active recombinant protein
CHK, CHK2 checkpoint homolog
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O96017 |
---|---|
Concentration | 0.1 |
Calculated MW | 88.0 kDa |
Gene ID | 11200 |
---|---|
Gene Symbol | CHK2 |
Other Names | CHK, CHK2 checkpoint homolog |
Source | Baculovirus (Sf9 insect cells) |
Assay&Purity | SDS-PAGE; ≥90% |
Assay2&Purity2 | HPLC; |
Recombinant | Yes |
Format | Liquid |
Storage | -80°C; Recombinant proteins in storage buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, 25% glycerol). |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Chk2 is the mammalian homolog of the Saccharomyces cerevisiae Rad53 and Schizosaccharomyces pombe Cds1 protein kinases required for the DNA damage and replication checkpoints. Chk2 is rapidly phosphorylated and activated in response to replication blocks and DNA damage; the response to DNA damage occurs in an ataxia telangiectasia mutated (ATM)-dependent manner (1). In vitro, Chk2 phosphorylates p53 on Ser-20 and dissociated preformed complexes of p53 with Mdm2, a protein that targets p53 for degradation (2). In vivo, ectopic expression of wild-type Chk2 leads to increased p53 stabilization after DNA damage, whereas expression of a dominant-negative Chk2 mutant abrogated both phosphorylation of p53 on Ser-20 and p53 stabilization. Thus, in response to DNA damage, Chk2 stabilizes the p53 tumor suppressor protein leading to cell cycle arrest in G1. Chk2 is directly phosphorylated by ATM in response to ionizing radiation (3). The phosphorylation occurs in the Ser-Gln/Thr-Gln (SQ/TQ) cluster domain (SCD) on Chk2, which contains seven SQ/TQ motifs, and Thr68 is the major in vitro phosphorylation site by ATM.
References
Matsuoka S.,et al.Science 282:1893-1897(1998).
Blasina A.,et al.Curr. Biol. 9:1-10(1999).
Brown A.L.,et al.Proc. Natl. Acad. Sci. U.S.A. 96:3745-3750(1999).
Staalesen V.,et al.Oncogene 23:8535-8544(2004).
Collins J.E.,et al.Genome Biol. 5:R84.1-R84.11(2004).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.